Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 trial of an unspecified antitumor agent (Japan, jRCT2080224853)
jRCT2080224853Phase 2Completed
- Start
- Sep 2019
- Countries
- 1
01
Overview
Phase 2 trial in cancer. Started Sep 2019; status: completed.
02
Conditions
cancer
Beyond the preview
Go deeper on jRCT2080224853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224853.